Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RYLAND E MELFORD

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1598874869
CMS profile
254064
Location
LAGUNA HILLS, CA

General Payments · PY2018–2024

$10,835.97

  • Reported across 448 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$764.31

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $764.31 35

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,514.81 92
PY2019 $2,755.54 92
PY2020 $1,146.73 49
PY2021 $1,967.39 69
PY2022 $1,522.42 62
PY2023 $1,164.77 49
PY2024 $764.31 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $14.60 10/07/2024 Food and Beverage Undisputed 01/23/2026 1125146281 CMS
Alnylam Pharmaceuticals Inc. $27.71 07/17/2024 Food and Beverage Undisputed 01/23/2026 1125857572 CMS
Alnylam Pharmaceuticals Inc. $24.73 08/29/2024 Food and Beverage Undisputed 01/23/2026 1125857608 CMS
Amgen Inc. $17.09 07/30/2024 Food and Beverage Undisputed 01/23/2026 1115926045 CMS
AstraZeneca Pharmaceuticals LP $33.27 06/20/2024 Food and Beverage Undisputed 01/23/2026 1105278033 CMS
ATRICURE, INC. $15.07 11/22/2024 Food and Beverage Undisputed 01/23/2026 1132872553 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.09 01/31/2024 Food and Beverage Undisputed 01/23/2026 1086214595 CMS
BIOTRONIK INC. $82.29 01/08/2024 Food and Beverage Undisputed 01/23/2026 1145801755 CMS
Boston Scientific Corporation $47.75 09/07/2024 Food and Beverage Undisputed 01/23/2026 1092719084 CMS
E.R. Squibb & Sons, L.L.C. $18.55 06/17/2024 Food and Beverage Undisputed 01/23/2026 1101432529 CMS
Esperion Therapeutics, Inc. $13.81 03/25/2024 Food and Beverage Undisputed 01/23/2026 1129446594 CMS
Esperion Therapeutics, Inc. $16.05 05/14/2024 Food and Beverage Undisputed 01/23/2026 1129446596 CMS
Esperion Therapeutics, Inc. $18.34 07/24/2024 Food and Beverage Undisputed 01/23/2026 1129446598 CMS
Kestra Medical Technology Services, Inc. $15.67 01/10/2024 Food and Beverage Undisputed 01/23/2026 1152378255 CMS
Kestra Medical Technology Services, Inc. $17.15 03/05/2024 Food and Beverage Undisputed 01/23/2026 1152378253 CMS
Kiniksa Pharmaceuticals International, plc $21.26 07/15/2024 Food and Beverage Undisputed 01/23/2026 1154862952 CMS
Merck Sharp & Dohme LLC $14.45 01/24/2024 Food and Beverage Undisputed 01/23/2026 1141813405 CMS
Merck Sharp & Dohme LLC $26.26 08/13/2024 Food and Beverage Undisputed 01/23/2026 1141813403 CMS
Novartis Pharmaceuticals Corporation $17.00 02/06/2024 Food and Beverage Undisputed 01/23/2026 1087079802 CMS
Novartis Pharmaceuticals Corporation $14.96 02/27/2024 Food and Beverage Undisputed 01/23/2026 1087079818 CMS
Novartis Pharmaceuticals Corporation $30.96 03/07/2024 Food and Beverage Undisputed 01/23/2026 1087079814 CMS
Novartis Pharmaceuticals Corporation $22.37 04/24/2024 Food and Beverage Undisputed 01/23/2026 1087079836 CMS
Novartis Pharmaceuticals Corporation $20.72 05/23/2024 Food and Beverage Undisputed 01/23/2026 1087079844 CMS
Novartis Pharmaceuticals Corporation $17.13 06/18/2024 Food and Beverage Undisputed 01/23/2026 1087079852 CMS
Novartis Pharmaceuticals Corporation $8.78 07/03/2024 Food and Beverage Undisputed 01/23/2026 1087079854 CMS
Novartis Pharmaceuticals Corporation $9.77 08/08/2024 Food and Beverage Undisputed 01/23/2026 1087079864 CMS
Novartis Pharmaceuticals Corporation $7.69 10/22/2024 Food and Beverage Undisputed 01/23/2026 1087079896 CMS
Novartis Pharmaceuticals Corporation $17.41 11/21/2024 Food and Beverage Undisputed 01/23/2026 1087079900 CMS
Novo Nordisk Inc $21.83 05/29/2024 Food and Beverage Undisputed 01/23/2026 1097196959 CMS
Novo Nordisk Inc $23.72 11/06/2024 Food and Beverage Undisputed 01/23/2026 1097282766 CMS
PFIZER INC. $20.67 10/09/2024 Food and Beverage Undisputed 01/23/2026 1131970785 CMS
SANOFI-AVENTIS U.S. LLC $21.68 01/18/2024 Food and Beverage Undisputed 01/23/2026 1139694194 CMS
SCPHARMACEUTICALS INC. $21.83 02/15/2024 Food and Beverage Undisputed 01/23/2026 1132251612 CMS
SCPHARMACEUTICALS INC. $25.00 03/21/2024 Food and Beverage Undisputed 01/23/2026 1132263043 CMS
SCPHARMACEUTICALS INC. $25.65 08/15/2024 Food and Beverage Undisputed 01/23/2026 1132293558 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.